- Home
- TXO vs PRME Comparison
TXO vs PRME Comparison
Compare TXO & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXO
- PRME
- Stock Information
- Founded
- TXO 2012
- PRME 2019
- Country
- TXO United States
- PRME United States
- Employees
- TXO N/A
- PRME N/A
- Industry
- TXO Oil & Gas Production
- PRME Medicinal Chemicals and Botanical Products
- Sector
- TXO Energy
- PRME Health Care
- Exchange
- TXO Nasdaq
- PRME Nasdaq
- Market Cap
- TXO 701.2M
- PRME 601.1M
- IPO Year
- TXO 2023
- PRME 2022
- Fundamental
- Price
- TXO $13.06
- PRME $3.80
- Analyst Decision
- TXO Strong Buy
- PRME Buy
- Analyst Count
- TXO 2
- PRME 6
- Target Price
- TXO $20.50
- PRME $9.31
- AVG Volume (30 Days)
- TXO 151.4K
- PRME 4.1M
- Earning Date
- TXO 11-04-2025
- PRME 11-07-2025
- Dividend Yield
- TXO 18.40%
- PRME N/A
- EPS Growth
- TXO N/A
- PRME N/A
- EPS
- TXO 0.36
- PRME N/A
- Revenue
- TXO $364,412,000.00
- PRME $5,977,000.00
- Revenue This Year
- TXO $32.13
- PRME $179.58
- Revenue Next Year
- TXO $11.48
- PRME N/A
- P/E Ratio
- TXO $36.42
- PRME N/A
- Revenue Growth
- TXO 27.66
- PRME 647.13
- 52 Week Low
- TXO $12.61
- PRME $1.11
- 52 Week High
- TXO $20.70
- PRME $6.94
- Technical
- Relative Strength Index (RSI)
- TXO 41.54
- PRME 43.32
- Support Level
- TXO $13.15
- PRME $3.17
- Resistance Level
- TXO $14.09
- PRME $4.00
- Average True Range (ATR)
- TXO 0.33
- PRME 0.43
- MACD
- TXO 0.01
- PRME -0.04
- Stochastic Oscillator
- TXO 19.36
- PRME 34.50
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.